Central Regeneration Changes the Economics of PFAS Treatment

Per- and polyfluoroalkyl substances (PFAS) treatment is still too often discussed as a media choice. Use granular activated carbon. Use single-use resin. Meet the target and move on.

That framing is no longer enough.

For municipal systems and private water providers, the harder question is not only whether a treatment train can remove PFAS today. It is whether that approach still makes technical, financial and operational sense after years of replacement cycles, disposal costs and tighter oversight. The market is moving beyond a narrow conversation about initial treatment performance and toward a broader one about lifecycle responsibility.

That shift is why central regeneration and Regen as a Service deserve more attention.

Onterris’s Central Regeneration model is built around a hub-and-spoke approach in which spent ion exchange media or vessels are sent to a centralized regeneration hub, restored for reuse and returned to service. The model is designed to lower lifecycle costs, reduce waste volume and treat all PFAS compounds, including ultrashort chains. It also supports easier integration with bolt-on destruction technologies, which matters as owners look for treatment systems that can evolve with the regulatory landscape.

Regeneration is not simply a feature of the media. It is a different operating model for PFAS treatment, one that changes how utilities think about cost, waste and long-term stewardship.

Single-use treatment can be effective, but it often locks owners into a repeating cycle: purchase media, install it, exhaust it, remove it and manage the waste. That model may solve the first compliance milestone, but it can create an expensive and persistent operating burden over the life of the asset.

Many drinking water systems are installing or expanding PFAS treatment to meet new maximum contaminant level requirements with single-use ion exchange media that drives high replacement and disposal costs year after year. Regen as a Service offers a different path. Systems can move from single-use media to regenerable media at the same upfront capital cost and media supply price point, then capture lower operating costs over time through centralized regeneration.

That distinction matters because capital cost still dominates many procurement discussions. It is immediate, visible and easy to compare. Operating cost and waste exposure are easier to underestimate because they arrive slowly. Yet those are the categories that determine whether a PFAS treatment strategy remains affordable and defensible over 10, 20 or 30 years.

The lifecycle case is compelling: low total cost of ownership, minimal waste generation, a streamlined supply chain and future-proof treatment capability. Central regeneration is also positioned to deliver a 1,000,000:1 reduction in waste volume.

That number stands out because it shifts the discussion from removal efficiency alone to whole-system performance. Waste concentration and waste minimization are not secondary benefits. They are part of the core value of the treatment strategy.

The most important feature of central regeneration may be what it removes from the site-level burden.

Under a conventional approach, an owner is responsible not only for running treatment but also for the recurring commercial and environmental consequences of exhausted media. Under the central regeneration model, the regeneration step is handled off-site by a specialized hub. Customers do not need to own, operate or permit a regeneration plant on-site. Spent media is transported to a central regeneration facility, regenerated under controlled conditions and returned for reuse through a simple fee structure. Each client’s media is kept separate to maintain traceability.

That separation is more than a logistics detail. In drinking water treatment, chain of custody, process control and performance assurance are central to trust. A centralized model works when it simplifies the burden on the local operator while keeping quality discipline high behind the scenes.

This is also what makes Regen as a Service scalable. It lowers the barrier to adoption. Utilities gain access to the benefits of regeneration without taking on the capital complexity, staffing burden or permitting challenge of an on-site regeneration plant. For teams already stretched across compliance, operations and capital planning, that matters.

Onterris is relocating one of its modular regeneration units from Portland, Maine to the Raleigh-Durham area of North Carolina while a permanent regeneration facility is built there. That move strengthens the case for central regeneration because it shows a clear path from concept to operating infrastructure. For utilities evaluating treatment options now, near-term service capacity is just as important as long-term vision.

Any claim about lower cost or lower waste becomes irrelevant if treatment performance weakens under real-world conditions. The encouraging point is that regeneration is not presented as a tradeoff against removal performance.

Testing on drinking water sources has shown very similar PFAS treatment performance between regenerable resin and single-use resin. The available comparison includes perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), with charts illustrating comparable treatment behavior across the tested media types.

The operating case is also notable. One case example reports 13 regeneration cycles over six years of operation, with 13 media changeouts avoided. It also notes that PFOS was treated to non-detect and that the polish vessel provided a reliable backstop with minimal PFAS loading from the primary RePURE vessels.

That is an important combination of signals. Comparable performance in testing. Repeated regeneration in operation. Avoided changeouts over multiple years. Those details move the conversation beyond theory and toward repeatable operating value.

There is also an adoption point that removes friction for drinking water applications. The regeneration media is already NSF 61 certified/approved, which helps address a practical concern that often slows adoption of newer treatment media in municipal and private systems.

The most persuasive part of the central regeneration story is that the sustainability case and the financial case reinforce each other.

Lifecycle analyses indicate that Regen as a Service can reduce long-term PFAS treatment cost by up to about 40% compared with single-use ion exchange. In a 5 million gallons per day comparison, the 30-year lifecycle cost is estimated at roughly $14.6 million for single-use ion exchange versus roughly $8.8 million for a system paired with Regen as a Service, with similar capital cost but lower annual operating cost.

At larger scale, the same pattern holds. In the 13.5 MGD example, capital cost for single-use ion exchange and Regen as a Service is shown at $4.9 million, while annual operating cost falls from $1.2 million per year for single-use ion exchange to $0.66 million per year for Regen as a Service. The same example shows direct regenerable ion exchange with annual operating cost of $0.08 million per year.

At 80 MGD, the modeled economics are even more striking: approximately $177 million in operating cost savings over 30 years versus granular activated carbon, with RePURE payback in less than two years. The same analysis shows about $28 million in 30-year savings for regenerable ion exchange and about $14 million in 30-year savings for regeneration service.

That pattern is worth pausing on. Central regeneration does not create savings through one breakthrough metric. It creates savings by removing repeated cost from the system: less virgin media demand, fewer changeouts, less disposal volume and a lower long-term service burden. That is why the waste argument and the cost argument are inseparable.

Sources: Drinking Water White Paper, Regeneration as a Service brochure and Central Regeneration webpage.

Figure callout: The lifecycle cost charts show the cumulative cost gap widening over time between granular activated carbon, single-use ion exchange and regenerable media, particularly in the 80 MGD example. The RSSCT charts show similar treatment performance between regenerable and single-use resin in drinking water testing.

PFAS treatment is entering a more disciplined phase. The sector no longer needs proof that contaminants can be removed from water. It needs better answers to the harder questions: What happens to the waste? What happens to the cost curve? How does a system respond when regulations expand, analyte lists change or disposal scrutiny increases?

Central regeneration offers a stronger answer because it starts with lifecycle responsibility. It reduces the repeated waste and replacement burden that single-use models can create. It preserves operator focus by keeping regeneration off-site. It improves long-term cost visibility. And with a modular regeneration unit relocating to the Raleigh-Durham area while a permanent facility is built there, the model is moving toward practical deployment at the scale the market needs.

The strongest PFAS treatment strategy is not always the one with the simplest installation story. It is the one that still looks sound after years of operation, repeated compliance reporting and ongoing pressure to do more with less waste.

That is where central regeneration stands out. It turns PFAS treatment from a replacement cycle into a managed regeneration cycle. It keeps site operations simpler while improving the long-term economics of compliance. And it shows that cost control, performance and environmental stewardship can work together when the system is designed with all three in mind.